title: Targeted therapies in non-small-cell lung cancer management: no cost-effective strategies?
authors.affiliation: Centre Hospitalier Intercommunal Créteil, Paris XII, Créteil, France Christos.chouaid@chicreteil.fr.
authors.forename: Christos
authors.initials: C
authors.lastname: Chouaid
authors.affiliation: Gustave Roussy and Paris-Sud University, Paris, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Borget
authors.affiliation: Centre Hospitalier Universitaire Limoges, Limoges, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Vergnenegre
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D007150:Immunohistochemistry / Q000191:economics*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics*; D015514:Oncogene Proteins, Fusion / Q000032:analysis*; D011720:Pyrazoles / Q000191:economics*; D011725:Pyridines / Q000191:economics*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion; D011720:Pyrazoles; D011725:Pyridines